動物用API（原薬）市場：治療カテゴリー別、合成タイプ、受託アウトソーシングタイプ、薬剤タイプ別-2032年までの世界予測

動物用API（原薬）の世界市場は、ペット保険需要の増加により、2032年まで大きく成長すると予測されています。

例えば、ある情報源によると、2021年に米国で保険に加入したペットの総数は390万匹で、2020年から28%の増加を示しています。

また、ペット保険業界における政府の取り組みが活発化していることも、2032年までの市場需要に拍車をかけると考えられます。一例を挙げると、2019年にNAICは、ペット保険に関する償還給付、既往症、定義、違反、生産者ライセンス、情報開示、規制などの問題に対処するためのモデル法開発の要請を受け入れました。

別の例では、動物の健康と獣医学に関する信頼できる情報源であるVETMEDが、動物用API（原薬）の範囲と抗菌剤耐性の広がりをよりよく理解するために、動物用API（原薬）の環境発生を数値化すると発表しました。VETMEDは、今回の取引により、これらの医薬品の意義をより深く理解することができるようになるとしています。

全体として、世界の動物用API（原薬）市場は、治療カテゴリー、合成、受託アウトソーシング、医薬品、地域の観点から区分されます。

治療カテゴリーに基づくと、2022年に56億米ドル以上の評価額を記録したNSAIDsセグメントによって市場が特徴付けられると考えられます。NSAIDsは、動物の痛み、発熱、その他の炎症の兆候をコントロールするためにますます使用されています。ある研究では、NSAIDs（非ステロイド性抗炎症薬）は、英国の獣医外科医が犬の変形性関節症の治療に一般的に使用されていることが確認されています。

合成に基づくと、生物学的原薬セグメントは2022年に107億米ドル以上の収益シェアを占め、今後10年間は堅調な成長を遂げるでしょう。このセグメントの拡大は、動物の様々な健康問題の診断や治療に使用される生物学的活性物質に対する需要の高まりに起因しています。また、治療薬のカテゴリーに属する疾患の数が増加しており、これがセグメント拡大の原動力となります。

受託アウトソーシングをベースとした場合、CDMOセグメントは2023-2032年にかけて大きく成長するでしょう。これは、CDMOが動物用APIに提供する利点やメリットにより、その採用が増加する結果となっています。

医薬品では、処方箋セグメントが2023年から2032年にかけて大きく成長すると考えられます。このセグメントの成長は、重度の病気を治療するための抗感染症薬、NSAIDs、抗生物質、ワクチンなど、さまざまな処方薬や治療薬の使用量の急増によってもたらされると予想されます。

地域別では、人獣共通感染症の流行が拡大していること、州の規制シナリオが良好であることから、世界の動物用API（原薬）市場は北米で大きく成長すると予想されます。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 動物用API（原薬）の業界洞察

• 業界別セグメンテーション
• 業界の情勢、2018年～2032年版
• 業界への影響要因
  • 促進要因
    • ペット保険の需要拡大
    • 動物の健康、心身の健康に対する意識の高まり
    • 畜産物の需要増
    • 政府の積極的な取り組み
    • 成長するペット飼育
  • 業界の潜在的リスク＆課題
    • 動物医療費の自己負担が少ない
    • 動物用医薬品の高コスト
• 成長性分析
  • 治療カテゴリー別
  • 合成の種類別
  • 受託アウトソーシングタイプ別
  • 薬剤の種類別
• COVID-19影響解析
• テクノロジー情勢
• サプライチェーン分析
• 主な市場動向
• パイプラインの解析
• 規制状況について
  • 米国
  • 欧州
  • アジア太平洋地域
• ベンダー・マトリックス分析
• ポーター分析
• PESTEL分析

第4章 競合情勢、2021年

• イントロダクション
• 企業マトリックス分析、2021年
• 戦略ダッシュボード、2021年

第5章 動物用API（原薬）市場：治療カテゴリー別

• 主なセグメント動向
• 抗感染症薬
• 抗寄生虫剤
• 非ステロイド系抗炎症薬
• バイオロジクス
• その他

第6章 動物用API（原薬）市場：合成タイプ別

• 主なセグメント動向
• 化学系API
• バイオロジカルAPI
• 高活性API（HPAPI）

第7章 動物用API（原薬）市場：受託アウトソーシングタイプ別

• 主なセグメント動向
• CDMO
• CMO

第8章 動物用API（原薬）市場：薬物タイプ別

• 主なセグメント動向
• 処方箋
• OTC

第9章 動物用API（原薬）市場：地域別

• 主な地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ地域
  • 南アフリカ
  • サウジアラビア
  • UAE

第10章 企業プロファイル

• Alivira Animal Health Ltd
• SUANFARMA
• Procyon Life Sciences
• Jiangsu Lingyun Pharmaceutical Co., Ltd
• Ofichem Group
• NGL Fine-Chem Ltd
• Huvepharma
• Excel Veterinary Healthcare
• Menadiona
• Indukern Group
• Vetpharma（Insud Pharma）
• Qilu Pharmaceutical（Inner Mongolia）Co., Ltd

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by therapeutic category (2022)
• TABLE 3. Market revenue, by synthesis type (2022)
• TABLE 4. Market share, by contract outsourcing type (2022)
• TABLE 5. Market share, by drug type (2022)
• TABLE 6. Market share, by region (2022)
• TABLE 7. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 8. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 9. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024 (USD Million)
• TABLE 10. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032 (USD Million)
• TABLE 11. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 12. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 13. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024 (USD Million)
• TABLE 14. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032 (USD Million)
• TABLE 15. Global veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024 (USD Million)
• TABLE 16. Global veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032 (USD Million)
• TABLE 17. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 18. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 19. Industry impact forces
• TABLE 20. Comprehensive study of active pharmaceutical ingredients supply chain of the U.S. and Europe
• TABLE 21. Veterinary APIs under development for the manufacturing of animal drugs
• TABLE 22. Application of GMP guidance to API manufacturing
• TABLE 23. Anti-infectives market, 2018 - 2024 (USD Million)
• TABLE 24. Anti-infectives market, 2025 - 2032 (USD Million)
• TABLE 25. Anti-parasitic market, 2018 - 2024 (USD Million)
• TABLE 26. Anti-parasitic market, 2025 - 2032 (USD Million)
• TABLE 27. NSAIDs market, 2018 - 2024 (USD Million)
• TABLE 28. NSAIDs market, 2025 - 2032 (USD Million)
• TABLE 29. Biologics market, 2018 - 2024 (USD Million)
• TABLE 30. Biologics market, 2025 - 2032 (USD Million)
• TABLE 31. Others market, 2018 - 2024 (USD Million)
• TABLE 32. Others market, 2025 - 2032 (USD Million)
• TABLE 33. Chemical based API market, 2018 - 2024 (USD Million)
• TABLE 34. Chemical based API market, 2025 - 2032 (USD Million)
• TABLE 35. Biological API market, 2018 - 2024 (USD Million)
• TABLE 36. Biological API market, 2025 - 2032 (USD Million)
• TABLE 37. Highly potent API (HPAPI) market, 2018 - 2024 (USD Million)
• TABLE 38. Highly potent API (HPAPI) market, 2025 - 2032 (USD Million)
• TABLE 39. CDMO market, 2018 - 2024 (USD Million)
• TABLE 40. CDMO market, 2025 - 2032 (USD Million)
• TABLE 41. CMO market, 2018 - 2024 (USD Million)
• TABLE 42. CMO market, 2025 - 2032 (USD Million)
• TABLE 43. Prescription market, 2018 - 2024 (USD Million)
• TABLE 44. Prescription market, 2025 - 2032 (USD Million)
• TABLE 45. OTC market, 2018 - 2024 (USD Million)
• TABLE 46. OTC market, 2025 - 2032 (USD Million)
• TABLE 47. North America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 48. North America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 49. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 50. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 51. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 52. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 53. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 54. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 55. North America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 56. North America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 57. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 58. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 59. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 60. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 61. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 62. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 63. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 64. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 65. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 66. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 67. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 68. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 69. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 70. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 71. Canada veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 72. Canada veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 73. Europe veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 74. Europe veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 75. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 76. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 77. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 78. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 79. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 80. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 81. Europe veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 82. Europe veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 83. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 84. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 85. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 86. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 87. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 88. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 89. Germany veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 90. Germany veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 91. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 92. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 93. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 94. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 95. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 96. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 97. UK veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 98. UK veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 99. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 100. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 101. France veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 102. France veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 103. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 104. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 105. France veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 106. France veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 107. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 108. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 109. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 110. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 111. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 112. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 113. Spain veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 114. Spain veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 115. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 116. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 117. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 118. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 119. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 120. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 121. Italy veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 122. Italy veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 123. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 124. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 125. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 126. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 127. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 128. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 129. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 130. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 131. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 132. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 133. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 134. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 135. China veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 136. China veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 137. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 138. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 139. China veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 140. China veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 141. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 142. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 143. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 144. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 145. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 146. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 147. Japan veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 148. Japan veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 149. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 150. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 151. India veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 152. India veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 153. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 154. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 155. India veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 156. India veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 157. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 158. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 159. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 160. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 161. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 162. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 163. Australia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 164. Australia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 165. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 166. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 167. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 168. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 169. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 170. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 171. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 172. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 173. Latin America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 174. Latin America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 175. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 176. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 177. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 178. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 179. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 180. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 181. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 182. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 183. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 184. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 185. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 186. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 187. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 188. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 189. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 190. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 191. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 192. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 193. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 194. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 195. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 196. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 197. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 198. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 199. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 200. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 201. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 202. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 203. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 204. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 205. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 206. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 207. MEA veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 208. MEA veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 209. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 210. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 211. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 212. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 213. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 214. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 215. MEA veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 216. MEA veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 217. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 218. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 219. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 220. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 221. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 222. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 223. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 224. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 225. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 226. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 227. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 228. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 229. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 230. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 231. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 232. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 233. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 234. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 235. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 236. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 237. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 238. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 239. UAE veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 240. UAE veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 9 Growth potential analysis, by therapeutic category
• FIG. 10 Growth potential analysis, by synthesis type
• FIG. 11 Growth potential analysis, by contract outsourcing type
• FIG. 12 Growth potential analysis, by drug type
• FIG. 13 Supply chain based on traditional veterinary API manufacturing
• FIG. 14 Porter's analysis
• FIG. 15 PESTEL analysis
• FIG. 16 Company matrix analysis, 2021
• FIG. 17 Strategy dashboard, 2021

Global Veterinary Active Pharmaceutical Ingredients Market is poised to grow significantly through 2032, owing to the increasing demand for pet insurance. For instance, according to a source, the total number of pets that were insured in the U.S. in 2021 was 3.9 million, depicting an increase of 28% from 2020.

Besides, an upsurge in favorable government initiatives in the pet insurance industry will fuel the market demand by 2032. To cite an instance, the NAIC in 2019 accepted the request for Model Law development to address issues such as reimbursement benefits, pre-existing conditions, definitions, violations, producer licensing, disclosures, and regulations regarding pet insurance.

In another instance, VETMED, a reliable source for animal health and veterinary medicine announced quantifying the environmental occurrence of veterinary active pharmaceutical ingredients to better understand the scope of active pharmaceutical ingredients and the spreading of antimicrobial resistance. VETMED claims that the deal will help it to better understand the significance of these medications.

Overall, the global veterinary active pharmaceutical ingredients market is segmented in terms of therapeutic category, synthesis, contract outsourcing, drug, and region.

Based on the therapeutic category, the market is likely to be characterized by the NSAIDs segment, which held a valuation of more than USD 5.6 billion in 2022. NSAIDs are increasingly used to control pain, fever, and other signs of inflammation in animals. A study observed that NSAIDs (Non-steroidal anti-inflammatory drugs) are commonly used to treat canine osteoarthritis by veterinary surgeons in the UK.

Based on synthesis, the biological API segment held more than USD 10.7 billion revenue share in 2022 and will grow robustly over the next ten years. The segmental expansion can be credited to the growing demand for biologically active substances which are used to diagnose and treat various health issues among animals. Besides, there is a rise in the number of diseases in the therapeutic category, which will drive segmental expansion.

On the basis of contract outsourcing, the CDMO segment will grow significantly through 2023-2032, owing to the benefits and advantages offered by them to the veterinary APIs, resulting in their increasing adoption.

In the context of the drug, the prescription segment will grow significantly between 2023 and 2032. The growth of this segment is anticipated to be driven by the surging usage of a range of prescribed medications and therapeutics including anti-infectives, NSAIDs, antibiotics, and vaccines, to treat severe ailments.

In the regional context, the global veterinary active pharmaceutical ingredients market will grow significantly in North America, due to the growing prevalence of zoonotic diseases and a favorable State-backed regulatory scenario.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
  • 2.2.1 Therapeutic category trends
  • 2.2.2 Synthesis type trends
  • 2.2.3 Contract outsourcing type trends
  • 2.2.4 Drug type trends
  • 2.2.5 Regional trends

Chapter 3 Veterinary Active Pharmaceutical Ingredients Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing demand for pet insurance
    • 3.3.1.2 Surging awareness of animal health, physical and mental well-being
    • 3.3.1.3 Increasing demand for animal products
    • 3.3.1.4 Favorable government initiatives
    • 3.3.1.5 Growing pet adoption
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Low out of pocket expenditure on veterinary care
    • 3.3.2.2 High cost of veterinary medicines
• 3.4 Growth potential analysis
  • 3.4.1 By therapeutic category
  • 3.4.2 By synthesis type
  • 3.4.3 By contract outsourcing type
  • 3.4.4 By drug type
• 3.5 COVID-19 impact analysis
• 3.6 Technology landscape
• 3.7 Supply chain analysis
• 3.8 Key market trends
• 3.9 Pipeline analysis
• 3.10 Regulatory landscape
  • 3.10.1 U.S.
  • 3.10.2 Europe
  • 3.10.3 Asia Pacific
• 3.11 Vendor matrix analysis
• 3.12 Porter's analysis
  • 3.12.1 Industry rivalry
  • 3.12.2 Bargaining power of suppliers
  • 3.12.3 Bargaining power of buyers
  • 3.12.4 Threat of substitute
  • 3.12.5 Threat of new entrants
• 3.13 PESTEL analysis
  • 3.13.1 Political
  • 3.13.2 Economical
  • 3.13.3 Social
  • 3.13.4 Technological
  • 3.13.5 Legal
  • 3.13.6 Environmental

Chapter 4 Competitive Landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Veterinary Active Pharmaceutical Ingredients Market, By Therapeutic Category

• 5.1 Key segment trends
• 5.2 Anti-infectives
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Anti-parasitic
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 NSAIDs
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Biologics
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.6 Others
  • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Veterinary Active Pharmaceutical Ingredients Market, By Synthesis Type

• 6.1 Key segment trends
• 6.2 Chemical based API
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Biological API
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Highly potent API (HPAPI)
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Veterinary Active Pharmaceutical Ingredients Market, By Contract Outsourcing Type

• 7.1 Key segment trends
• 7.2 CDMO
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 CMO
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Veterinary Active Pharmaceutical Ingredients Market, By Drug Type

• 8.1 Key segment trends
• 8.2 Prescription
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 OTC
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Veterinary Active Pharmaceutical Ingredients Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Alivira Animal Health Ltd
• 10.2 SUANFARMA
• 10.3 Procyon Life Sciences
• 10.4 Jiangsu Lingyun Pharmaceutical Co., Ltd
• 10.5 Ofichem Group
• 10.6 NGL Fine-Chem Ltd
• 10.7 Huvepharma
• 10.8 Excel Veterinary Healthcare
• 10.9 Menadiona
• 10.10 Indukern Group
• 10.11 Vetpharma (Insud Pharma)
• 10.12 Qilu Pharmaceutical (Inner Mongolia) Co., Ltd